Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Cardiovascular Abnormalities Clinical Trials

A listing of Cardiovascular Abnormalities medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (8) clinical trials

A 8 to 12 Week Randomized, Double-Blind Study to Compare the Fixed-Dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10mg Monotherapy as First Line Therapy in Type 2 Diebetes Patients with Hypertension (High Blood Pressure) Patient Inclusion Criteria: Men or Women 18 Years of Age or Older May ...

Phase

This study is looking at investigational drug, SAR236553, in patients who experienced a coronary event. One of the main risk factors for developing coronary heart disease is high levels of cholesterol in the blood, in particular high levels of a particular type of cholesterol called LDL-cholesterol (bad cholesterol). SAR236553 is ...

Phase

We are currently looking for patients with Type 2 Diabetes and vascular disease. This clinical trial consists of approximately 8 visits in the first 12 months over a 6 year study period. Compensation up to $50.00 per visit

Phase

A nine year study comparing the cardiovascular safety of allopurinol and febuxostat (Uloric) in patients with gout and cardiovascular comorbidities

Phase

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events.

Phase

This is an event driven study to reach statistical power given all other assumptions. Subjects will visit the clinic 1 month after randomization and at regular intervals thereafter. Additionally, for any subject prematurely discontinuing study medication, assessments will be conducted every 6 months for the collection of study endpoints.

Phase

Heartflow (AFFECTS)

The overall objective of the AFFECTS Study is to assess agreement between SPECT and FFRct in identifying vessel-specific, hemodynamically significant CAD in patients scheduled for invasive coronary angiography (ICA) based on abnormal SPECT myocardial perfusion scans. In particular, the study will evaluate the ability of FFRct to correctly rule out ...

Phase